Tag: GHRH(1-29)

Bioactivity of Growth Hormone Releasing Hormone (1-29) Analogues After SC Injection in Man

This 1989 study by Aitman et al. assessed the pharmacological effects of native GHRH(1-29)NH₂ and its synthetic analogue [Ac-D-Tyr¹,D-Ala²]-GHRH(1-29)NH₂ in healthy male volunteers following subcutaneous injection (3 µg/kg). Despite prior evidence of enhanced activity in animal models, the study found no significant differences between the native and analogue forms in

Read More »

Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group

This randomized controlled trial evaluated the effectiveness of daily subcutaneous administration of growth hormone-releasing hormone (GHRH(1-29)) in 110 children with growth hormone deficiency. Over a 12-month period, the treatment significantly increased height velocity, with an average increase to 8.0 cm/year at 6 months and 7.2 cm/year at 12 months. At

Read More »